RSS YouTube Flickr
News

Loughborough study supports doping-specific legislation

November 15, 2012

A recently published study from the University of Loughborough in the UK has shown that countries with legislation specific to performance enhancing drugs were better equipped to address the problem of doping in sport.

‘The use of legislation in relation to controlling the production, movement, importation, distribution and supply of performance-enhancing drugs in sport (PEDS)’ by Barrie Houlihan and Borja Garcia produced a number of key findings that will enable WADA to continue to stress the importance of government’s implementing anti-doping legislation.

In particular, the research conducted by the Institute of Sport and Leisure Policy at Loughborough shows that countries with PEDS-specific legislation are more likely to cover the full WADA list of prohibited substances.

Furthermore, the National Anti-Doping Organizations in those countries are more likely to have a role in deciding whether to launch an anti-doping investigation.

The study – jointly funded by UNESCO and WADA – also shows that countries with PEDS-specific legislation are more likely to share anti-doping information with Interpol, while in countries without it there was more likelihood of PEDS trafficking receiving a lower operational priority amongst police forces.

“WADA has been saying for some time now that there needs to be a more coherent approach to fighting drugs in sport involving more public authorities, and this study shows how anti-doping legislation can assist the anti-doping community,” said WADA President John Fahey.

“We will continue to encourage governments worldwide to implement such legislation so that mechanisms can be put in place to further address the issue, whether it is to allow NADOs a greater role or to increase the focus on trafficking of PEDS.”

The research has been designed to produce an analytical report on the status of anti-doping legislation in UNESCO Member States concerning the production, movement, importation, distribution and supply of performance-enhancing drugs.